NCT05496361View on ClinicalTrials.gov

A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

NACompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

January 24, 2021

Primary Completion Date

November 24, 2021

Study Completion Date

July 20, 2022

Conditions
AISAcute Ischemic StrokeLarge Vessel OcclusionThrombectomy
Interventions
DEVICE

Tianyi Revascularization Device

Revascularization Device using the Mechanical thrombectomy technique for recanalization of an occlusion large vessel in the brain

DEVICE

Solitaire FR Revascularization Device

Revascularization Device using the Mechanical thrombectomy technique for recanalization of an occlusion large vessel in the brain

Trial Locations (1)

Unknown

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
lead

Suzhou Zenith Vascular Scitech Co., Ltd.

INDUSTRY

NCT05496361 - A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter